`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`LUPIN LTD. and LUPIN PHARMACEUTICALS INC.
`
`Petitioners
`
`V.
`
`SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.
`
`Patent Owner
`
`IPR2015—01097 (US Patent No. 8,751,131)
`IPR2015-01099 (US Patent No. 8,669,290)
`IPR2015—O1100 (US Patent No. 8,927,606)
`IPR20l5-01105 (US Patent No. 8,871,813)‘
`
`PETITIONER’S NOTICE OF CROSS—EXAMINATION OF
`
`JOHN C. JAROSZ
`
`1 The word-for—word identical paper is filed in each proceeding identified in the
`heading. IPR20l6-00089 has beenjoined with IPR20l5-01097; IPR20l6-00091
`has been joined with IPR2015-01 100; and IPR2016-00090 has been joined with
`IPR20l5-01105. Each of these joined proceedings includes Petitioners
`InnoPharma Licensing, Inc., InnoPharma Licensing LLC, InnoPharma Inc., Mylan
`Pharmaceuticals Inc., and Mylan Inc. (collectively, “InnoPharma”) in addition to
`the parties identified above.
`
`IPR2015-01099
`IPR2015-01099
`IPR2015-01097
`IPR2015-01097
`IPR2015-01100
`IPR2015-01100
`IPR2015-01105
`IPR2015-01105
`
`Page 1
`
`Lupin EX1076
`Lupin EX1076
`Page 1
`
`
`
`Pursuant to 37 C.F.R. § 42.53, Lupin Ltd. and Lupin Pharmaceuticals Inc.
`
`(collectively, “Petitioners”), by and through its attorneys, will conduct a cross-
`
`examination by deposition of John C. Jarosz in connection with IPR2015-01097,
`
`IPR2015-01099, IPR2015—01l00, and IPR20l5-01105. Mr. Jarosz’s cross-
`
`examination will take place, as agreed by counsel for the parties, on March 16,
`
`2016, commencing at 9:00 a.m. (local time), at the offices of Finnegan, Henderson,
`
`Farabow, Garrett & Dunner, LLP, 901 New York Avenue, NW, Washington, DC
`
`20001-4413. Counsel for Patent Owner has represented that Mr. Jarosz is willing
`
`to appear at the time and location indicated above.
`
`The cross-examination will take place before a Notary Public or other officer
`
`authorized by law to administer oaths. It will be recorded using at least audiotape
`
`and/or stenographic means. Petitioners also intend to video record the cross-
`
`examination of Mr. Jarosz. The arrangements for the reporter and videographer
`
`will be made by counsel for Petitioners.
`
`March 9, 2016
`
`Respectfully submitted,
`
`/Deborah Yellin/
`
`Deborah H. Yellin
`
`Reg. No. 45,904
`CROWELL & MORING LLP
`
`Intellectual Property Group
`P.O. Box 14300
`
`Washington, DC 20044-4300
`
`Page 2
`
`
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that the foregoing document entitled
`
`PETITIONER’S NOTICE OF CROSS-EXAMINATION OF JOHN C. JAROSZ
`
`was served electronically via email on March 8, 2016 to Patent Owner’s counsel of
`
`record and counsel of record for Petitioners InnoPharma at the following:
`
`Patent Owner
`
`Bryan.Diner@finnegan.com
`
`Justin.Hasford@finnegan.com
`
`Joshua.Goldberg@f1nnegan.com
`
`Petitioners InnoPh arma
`
`Jitty.ma1ik@alston.com
`
`James.abe@alston.com
`
`Lance.soderstrom@a1ston.com
`
`March 9, 2016
`
`Respectfully submitted,
`
`/Deborah Yellin/
`
`Deborah H. Yellin
`
`Reg. No. 45,904
`CROWELL & MORING LLP
`
`Intellectual Property Group
`P.O. Box 14300
`
`Washington, DC 20044-4300
`
`Page 3